Ambiguity and misinformation on Italian hemp decree spread yet more confusion

A recent agreement to update the Italian list of officinal (medically usable) plants has caused some unfounded consternation in the country’s CBD industry.

The Italian Agriculture Ministry and the ministries of Health and Ecological Transition, along with the State-Regions Conference, reached an agreement to include hemp seeds and their by-products on the list – but at the same time inserting cannabis flowers, leaves or “active substances” (cannabinoids) destined for medical purposes under the regulatory framework of Narcotics Law n.309/90.

Read full article
I'm already a subscriber
Author default picture

CannIntelligence

This article was written by one of CannIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual cannabis and cannabinoid markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization